*Bausch + Lomb* is a leading global eye health company specializing in a wide range of eye care products, including contact lenses, lens care solutions, ophthalmic pharmaceuticals, and surgical equipment. Here’s an overview of the company:

*Key Information:*
– *Founded:* 1853 by John Jacob Bausch and Henry Lomb
– *Headquarters:* Vaughan, Ontario, Canada (with major operations in Bridgewater, New Jersey, USA)
– *Parent Company:* Currently owned by *Bausch Health Companies Inc.* (formerly Valeant Pharmaceuticals)
– *Focus:* Eye health, vision care, and surgical innovations

 *Major Product Categories:*
1. *Contact Lenses & Solutions:*
– Popular brands: *Biotrue®, PureVision®, Ultra®, SofLens®, ReNu®*
– Includes daily, monthly, and specialty contact lenses.

2. *Ophthalmic Pharmaceuticals:*
– Treatments for dry eye, glaucoma, allergies, and infections (e.g., *Lumify®* redness reliever, *Pataday®* for allergies).

3. *Surgical Products:*
– Cataract & refractive surgery equipment (e.g., *Stellaris®, **Technolas®* lasers).
– Intraocular lenses (IOLs) and viscoelastic products.

4. *Over-the-Counter (OTC) Eye Care:*
– Artificial tears, redness relievers, and vitamin supplements for eye health.

*Recent Developments:*
– In 2022, Bausch + Lomb became a *publicly traded company* again after spinning off from Bausch Health (ticker: *BLCO* on NYSE).
– The company continues to invest in *innovative technologies, including **presbyopia-correcting contact lenses* and *surgical advancements*.

*Reputation & Market Position:*
– One of the oldest and most trusted names in eye care.
– Competes with *Alcon (Novartis), Johnson & Johnson Vision, and CooperVision*.